Sabbin Sabuntawa akan Magungunan COVID-19 da Masu haɓakawa

Mun san cewa allurar rigakafi, tare da sauran matakan kiwon lafiyar jama'a da daidaikun mutane, suna aiki don rage yaduwar COVID-19 da bambance-bambancen sa. Koyaya, fitowar Omicron kwanan nan abin tunatarwa ne cewa cutar ta COVID-19 ba ta ƙare ba kuma muna rayuwa a cikin al'ummar duniya. A matsayinmu na manyan jami’an kiwon lafiya na kiwon lafiya, mun fahimci mahimmancin daidaiton duniya wajen rarraba alluran rigakafi da kuma rawar da rashin adalci ke takawa wajen bullowar sabbin bambance-bambancen. Yayin da muke ƙarin koyo game da wannan bambance-bambancen, za mu iya taimakawa wajen kiyaye ci gabanmu gaba ɗaya ta hanyar ci gaba da shirye-shiryen rigakafin COVID-19 da bin mahimman dabarun kiwon lafiyar jama'a waɗanda suka yi tasiri wajen taimakawa wajen sarrafa wannan annoba.

A matsayinmu na manyan jami’an kiwon lafiya na kiwon lafiya, mun fahimci mahimmancin daidaiton duniya wajen rarraba alluran rigakafi da kuma rawar da rashin adalci ke takawa wajen bullowar sabbin bambance-bambancen. Yayin da muke ƙarin koyo game da wannan bambance-bambancen, za mu iya taimakawa wajen kiyaye ci gabanmu gaba ɗaya ta hanyar ci gaba da shirye-shiryen rigakafin COVID-19 da bin mahimman dabarun kiwon lafiyar jama'a waɗanda suka yi tasiri wajen taimakawa wajen sarrafa wannan annoba.

Shaidar kimiyya, bayanai masu tasowa da shawarwarin ƙwararru suna ci gaba da sanar da mu kan mafi inganci amfani da rigakafin COVID-19 da aka amince da su a Kanada. NACI kwanan nan ta fitar da sabbin shawarwari game da masu haɓaka rigakafin COVID-19 dangane da haɓakar cututtukan cututtuka da shaida kan raguwar kariya akan lokaci. Cikakken jeri na farko tare da mRNA COVID-19 rigakafin ya ci gaba da kasancewa shawarwarin farko, kuma yakamata a ba da shi ga kowa da kowa a cikin rukunin shekarun da aka ba da izini ba tare da sabani ga maganin ba. NACI yanzu kuma tana ba da shawarwari game da allurai masu ƙarfafawa ga waɗanda shekarunsu suka wuce 18 zuwa sama idan aƙalla watanni 6 sun shuɗe daga jerin abubuwan farko.

Musamman, NACI ta ba da shawarar cewa ya kamata a ba da ƙarin allurai na rigakafin mRNA COVID-19 ga mutane masu zuwa: manya masu shekaru 50 ko fiye; manya da ke zaune a cikin gidajen kulawa na dogon lokaci don tsofaffi ko wasu wuraren zama masu taru waɗanda ke ba da kulawa ga tsofaffi; manya a cikin ko daga Ƙasashen Farko, al'ummomin Inuit ko Métis; masu karɓar jerin rigakafin ƙwayoyin cuta wanda aka kammala tare da allurar ƙwayoyin cuta kawai; da manyan ma'aikatan kiwon lafiya na gaba (masu hulɗar kai tsaye ta jiki tare da marasa lafiya) kuma ana iya ba da su ga manya masu shekaru 18 zuwa 49.

Cika jadawalin alluran rigakafin kashi biyu ga duk waɗanda suka cancanta ya kasance mai mahimmanci. Jerin farko yana ba da kyakkyawan kariya daga asibiti da mutuwa na dogon lokaci, musamman lokacin da aka ba da kashi na biyu aƙalla makonni 8 bayan kashi na farko. Mai haɓakawa yana dawo da kariya wanda ƙila ta ragu akan lokaci, yana ba da damar ƙarin kariya mai dorewa don taimakawa rage kamuwa da cuta, watsawa, da kuma a wasu al'ummomi, cututtuka masu tsanani. NACI ta kuma yi nazari kan bayanan mutanen da suka kamu da cutar a baya kuma ta ci gaba da ba da shawarar samun irin wannan jadawalin ga wadanda ba su kamu da cutar a baya ba. Alurar riga kafi ko da bayan kamuwa da cuta yana ba da mafi aminci da kariya mai dorewa daga SARS-CoV 2.

Kamar yadda muka gani a cikin bayaninmu da ya gabata game da masu haɓaka COVID-19, larduna da yankuna za su ci gaba da yin ɗorewa bisa shawarar NACI don aiwatar da dabarun rigakafi masu inganci a yankunansu. Mun kuduri aniyar yin amfani da mafi kyawun amfani da allurar COVID-19 bisa sabbin shaidu da shawarwarin kwararru don cimma burin mu na rage munanan cututtuka da mace-mace baki daya tare da kiyaye karfin tsarin kiwon lafiya, da rage watsawa don kare yawan masu hadarin gaske. A cikin shawarwarin don samar da abubuwan ƙarfafawa ga manya da ke zaune a Kanada, muna ɗaukar matakin yin taka tsantsan tare da tabbatar da cewa mun kare mutanen da ke cikin haɗari da kuma tsarin lafiyar mu.

NACI ta kuma fitar da ingantacciyar jagora kan amfani da rigakafin mRNA dangane da bayanan sa ido na baya-bayan nan daga Kanada, Amurka da Turai, game da lokuta masu wuya na myocarditis da pericarditis bayan allurar. Don rage haɗarin myocarditis ko pericarditis, wanda aka gano ya ɗan fi girma ga Moderna fiye da Pfizer a cikin matasa da matasa, NACI ta ba da shawarar cewa samfurin Pfizer-BioNTech 30 mcg ya fi son jerin farko a cikin waɗannan shekaru 12 zuwa 29 na shekaru. shekaru. Ana ba da shawarar tazara na mako 8 tsakanin kashi na farko da na biyu, saboda tsayin tazara irin wannan na iya samun ƙarancin haɗarin myocarditis fiye da ɗan gajeren lokaci kuma yana iya haifar da ingantaccen kariya. NACI kuma ta nuna cewa ana iya fifita samfurin Pfizer-BioNTech 30 mcg don adadin ƙarawa a cikin waɗannan shekarun 18 zuwa 29. Matasa da matasa masu shekaru 12 zuwa 29 da suka riga sun sami allurai ɗaya ko biyu na allurar Moderna fiye da ƴan makonnin da suka gabata ba sa buƙatar damuwa, saboda haɗarin myocarditis / pericarditis tare da wannan maganin yana da wuya kuma yana da illa. al'amarin yakan faru a cikin mako guda bayan alurar riga kafi. Kada a jinkirta yin rigakafin idan babu samfurin da aka fi so a lokacin rigakafin.

An ba da rahoton lokuta na myocarditis da/ko pericarditis bayan rigakafin mRNA COVID-19 a cikin kusan 1 cikin 50,000 ko 0.002% na allurai da aka yi. Gano abubuwan da ba kasafai suke faruwa ba kamar wannan nuni ne cewa tsarin sa ido a Kanada da na duniya suna da tasiri. Abubuwan da ba su da kyau (sakamakon illa) biyo bayan rigakafin COVID-19 suna faruwa, kuma mafi yawansu masu laushi ne kuma sun haɗa da ciwo a wurin allura ko ɗan zazzabi. Sama da allurai miliyan 60 na maganin COVID-19 an gudanar da su har zuwa yau a Kanada, tare da mummunan tasirin da ya ragu sosai (0.011% na duk allurai da aka gudanar). Nazarin lura, gami da na Kanada, sun ci gaba da nuna cewa duka allurar mRNA da aka amince da su suna haifar da babban tasirin rigakafin, musamman a kan cutar mai tsanani. Wasu nazarin, gami da waɗanda ke Kanada, suna ba da shawarar cewa rigakafin Moderna ya haifar da ɗan ƙaramin martani na rigakafi wanda ke haifar da babban tasiri wanda zai iya daɗewa idan aka kwatanta da allurar Pfizer-BioNTech COVID-19.

Manyan Jami’an Lafiya na Kanada suna maraba da nazarin NACI kuma suna gode musu don ba da sabbin shawarwarin su. A cikin bayaninmu da ya gabata game da haɗarin myocarditis da pericarditis bayan allurar rigakafin COVID-19, manyan jami'an kiwon lafiya sun yi la'akari da mahimmancin ba da fifiko ga aminci a cikin tsararren tsara shawarwarinmu da shirye-shiryen rigakafin kuma za mu ci gaba da yin hakan kuma isar da sakamakon binciken ga jama'ar Kanada. Za mu ci gaba da yin amfani da shaida don taimakawa tsara dabarun da za su iya rage haɗari har ma da gaba.

Mun fahimci cewa mutane a Kanada na iya samun tambayoyi game da sabbin shawarwari game da amfani da masu haɓaka COVID-19 da rigakafin mRNA, ya danganta da rukunin shekarun su, matsayin rigakafin da yanayi na musamman. Ya kamata daidaikun mutane su ci gaba da yin la'akari da fa'idodin fa'idodin duk alluran rigakafin da aka amince da su don amfani da su a Kanada don hana rashin lafiya mai tsanani, asibiti da mutuwa daga COVID-19. Ya kamata daidaikun mutane su nemi bayani daga mai ba da lafiyarsu ko hukumomin kiwon lafiyar jama'a na gida idan suna da tambayoyi game da samfuran rigakafin da suka fi dacewa da su.

Amfanin alluran rigakafin da aka ba izini a Kanada suna ci gaba da yin nauyi fiye da haɗari. Kamuwa da kwayar cutar da ke haifar da COVID-19 tana da alaƙa da rikice-rikice iri-iri waɗanda zasu iya haifar da asibiti da/ko mutuwa. Myocarditis ɗaya ne daga cikin sanannun rikice-rikice na kamuwa da cutar COVID-19, tare da haɗari mafi girma bayan kamuwa da cuta fiye da bayan rigakafin. Alurar riga kafi yana taimakawa wajen hana duk waɗannan rikice-rikice kuma, haɗe tare da wasu matakan kiwon lafiyar jama'a kamar sanya abin rufe fuska, guje wa cunkoson wurare, ƙara samun iska da nisantar jiki, na iya taimaka mana mu ji daɗin abubuwan da muka fi so. Manyan Jami’an Kiwon Lafiya na Kanada suna ci gaba da ƙarfafa duk mutane don yin rigakafi don kare kansu da na kusa da su.

Majalisar Manyan Jami'an Lafiya ta Lafiya ta hada da Babban Jami'in Lafiya na Lafiya daga kowace larduna da yanki, Babban Jami'in Kiwon Lafiyar Jama'a na Kanada, Babban Jami'in Kiwon Lafiyar Lafiya na Kanada, Babban Jami'in Kiwon Lafiyar Jama'a na Sabis na Yan Asalin Kanada, Babban Jami'in Kiwon Lafiyar Jama'a. Jami’in lafiya daga Hukumar Lafiya ta Majalisar Dinkin Duniya, da tsofaffin mambobin ofishin daga wasu sassan gwamnatin tarayya.